Skip to main content
Clinical Trials/ACTRN12622000050752
ACTRN12622000050752
Not yet recruiting
未知

The Effect of Exercise Prescription and Delivery in Congenital Heart Disease – The Congenital Heart Fitness Intervention Trial: CH-FIT

niversity of Sydney0 sites370 target enrollmentJanuary 17, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
niversity of Sydney
Enrollment
370
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged 10 to 55 years
  • \-People with congenital heart disease of moderate or great complexity
  • \-At least 6 months post surgical repair
  • \-Medically stable and on stable therapy for at least 3 months

Exclusion Criteria

  • \-Physiological stage D
  • \-Planned intervention within 2 years
  • \-Mental or physical disability that prevents participation in exercise training
  • \-Current or actively planned pregnancy within one year
  • \-Uncontrolled (systemic) hypertension at rest of exercise
  • \-Clinically unstable or recent major change in therapy within 3 months
  • \-COVID\-19 unvaccinated people despite being eligible according to ATAGI
  • \-People with unreliable internet connection
  • \-People currently participating in more than 30 minutes of sports or exercise training three times a week

Outcomes

Primary Outcomes

Not specified

Similar Trials